1. Home
  2. POWL vs BLTE Comparison

POWL vs BLTE Comparison

Compare POWL & BLTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Powell Industries Inc.

POWL

Powell Industries Inc.

N/A

Current Price

$193.30

Market Cap

7.2B

Sector

Energy

ML Signal

N/A

Logo Belite Bio Inc

BLTE

Belite Bio Inc

N/A

Current Price

$154.60

Market Cap

6.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
POWL
BLTE
Founded
1947
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.2B
6.0B
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
POWL
BLTE
Price
$193.30
$154.60
Analyst Decision
Buy
Strong Buy
Analyst Count
4
9
Target Price
★ $280.00
$228.89
AVG Volume (30 Days)
★ 470.9K
117.0K
Earning Date
11-17-2026
11-09-2026
Dividend Yield
★ 0.19%
N/A
EPS Growth
N/A
N/A
EPS
★ 3.81
N/A
Revenue
★ $448,716,000.00
N/A
Revenue This Year
$7.85
N/A
Revenue Next Year
$24.54
N/A
P/E Ratio
$49.68
★ N/A
Revenue Growth
★ 13.34
N/A
52 Week Low
$167.31
$78.71
52 Week High
$612.50
$200.00

Technical Indicators

Market Signals
Indicator
POWL
BLTE
Relative Strength Index (RSI) 51.62 39.00
Support Level $180.98 $145.95
Resistance Level $219.27 $161.10
Average True Range (ATR) 7.44 5.38
MACD 1.43 -1.98
Stochastic Oscillator 48.22 16.73

Price Performance

Historical Comparison
POWL
BLTE

About POWL Powell Industries Inc.

Powell Industries Inc is a United States-based company that develops, designs, manufactures, and services custom-engineered equipment and systems for electrical energy distribution, control, and monitoring. The company's principal products comprise integrated power control room substations, custom-engineered modules, electrical houses, traditional and arc-resistant distribution switchgear and control gear, and so on. These products are applied in oil and gas refining, offshore oil and gas production, petrochemical, pipeline, terminal, mining and metals, light-rail traction power, electric utility, pulp and paper, and other heavy industrial markets. The company generates the majority of its sales from the United States, and the rest from Canada, Europe, Asia Pacific, and other regions.

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases which have unmet medical need such as Geographic Atrophy (GA), the late atrophic (dry) form of age-related macular degeneration (AMD), and Stargardt disease type 1 (STGD1). In addition to its product candidate (tinlarebant) which is intended for the treatment of GA and STGD1, its drug development pipeline also includes a small molecule, orally administered compound, LBS-009, which is intended for the treatment of metabolic diseases such as non-alcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), type 2 diabetes (T2D), and gout.

Share on Social Networks: